Skip to main content

Table 1 Culture media for human GI organoids

From: Generation of 3D human gastrointestinal organoids: principle and applications

Organ

Source of organoids

Basal medium

EGF

Noggin

R-spondin1

Wnt3a

Gastrin

FGF10

Nicotinamide

A-83-01

SB202190

PGE2

Reference

Stomach

Corpus

+a

50 ng/ml

10% CM

10% CM

50% CM

1 nM

200 ng/ml

Facultative

2 μM

–

–

(Bartfeld et al., 2015)

Corpus and antrum

+

20 ng/ml

150 ng/ml

25% CM

50% CM

10 nM

150 ng/ml

10 mM

1 μM

2 μM

–

(Schlaermann et al., 2016)

Fundus

+

50 ng/ml

100 ng/ml

20% CM

50% CM

1 nM

200 ng/ml

10 mM

–

–

–

(Bertaux-Skeirik et al., 2015)

Intestine

Small intestine and colon

+

50 ng/ml

100 ng/ml

1 μg/ml

100 ng/ml

10 nM

–

10 mM

500 nM

10 μM

–

(Sato et al., 2011)

Small intestine and colon

+

-b

100 ng/ml

1 μg/ml

50% CM

10 nM

–

-b

500 nM

-b

–

(Fujii et al., 2018)

Colon

+

20 ng/ml

100 ng/ml

1 μg/ml

50% CM

1 μg/ml

–

10 mM

500 nMc

10 μM

10 nM

(Jung et al., 2011)

Colon

+a

50 ng/ml

100 ng/ml

10% CM

50% CM

10 nM

–

–

500 nM

10 μM

–

(Fujii et al., 2019)

Basal medium: Advanced DMEM/F12 + Penicinin/Streptomycin (1X) + Glutamine (2 mM) + N2 (1X) + B27 (1X) + N-acetylcysteine (1 mM) + HEPES (10 mM)

 
  1. Typically normal organoid and cancer organoid share the same culture medium. aN2 is absent in basal medium. bEGF, Nicotinamide and SB20190 is replaced by 50 ng/ml FGF-2 and 100 ng/ml IGF-1. cAnother TGF-β inhibitor LY2157299 is used instead of A83–01. CM Conditional medium